SARSIA SEED
Sarsia Seed is an Norwegian early stage Venture Capital firm with €90m under management. The funds specialize within LifeScience and Technology with international markets and has executed 33 investments. The Portfolio includes the listed companies BergenBio and Vaccibody which both have grown from early stage companies to €350m and €850m valuations under our strategic guidance and ownership. The Sarsia Seed investment strategy of early entry in research based and deep technology companies has proven very successful for both companies and LPs in the fund.
For more information please visit: